CARIS.
software company in Canada
- Reports this week
- 0
- Active events
- 0
- Connections
- 20
What's happening
Earlier this month
One to three months ago
-
CARIS gained FDA approval for its MI Cancer Seek test and was subsequently listed on the Nasdaq stock exchange.Some support1 report
-
Blue Owl provided a $700 million platform-wide loan to Caris on August 8, 2026.Some support1 report
-
Analyst ratings for Caris Life Sciences were published via MarketBeat, and the company is listed on the Nasdaq exchange.Some support4 reports
-
CARIS announced new leadership appointments, naming Luke Power as CFO and David Dean Halbert as CEO.Some support2 reports
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around CARIS this week
News at the entities that move CARIS most-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves CARIS
-
Securities and Exchange Commission StructuralBuilders FirstSource filed required reports with the Securities and Exchange Commission on August 16, 2026.Moves CARIS
-
Nasdaq StructuralStrategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock was listed on Nasdaq and a director sold company stock.Moves CARIS
-
SEC StructuralLaser Photonics Corporation hired Tim Peterman as Chief Financial Officer and engaged CBIZ for financial reporting consulting.Moves CARIS
-
Delta Air Lines StructuralDirector Michael Huerta disclosed the sale of company stock, while Bank of America raised its price target for Delta Air Lines.Moves CARIS
-
MarketBeat StructuralLeerink Partners and Barclays raised price targets on Elevance Health, while MarketBeat reported consensus ratings.Moves CARIS
Connections
The 13 strongest of 20, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
CARIS is formally listed and traded on the Nasdaq stock exchange.
-
Luke Power Structural
Luke Power serves as the Chief Financial Officer for CARIS.
-
SEC Structural
CARIS is formally regulated by the SEC, requiring the company to file transactions under SEC oversight.
-
Delta Air Lines Structural
Delta Air Lines is a lease counterparty for CARIS engines, establishing a supply chain dependency.
-
American Airlines Transactional
American Airlines relies on CARIS as a lease counterparty for engine supply.
-
FDA Structural
The FDA granted regulatory approval to CARIS for its MI Cancer Seek test.
-
David Dean Halbert Structural
David Dean Halbert serves as the Founder and CEO of CARIS.
-
Zippy Structural
CARIS holds a 15% financial interest in Zippy.
Show all 13 connections
-
Texas Shared context
CARIS is located and operates within the geographic and regulatory context of the state of Texas.
-
Securities and Exchange Commission Structural
The SEC has alleged that CARIS engaged in a cherry-picking scheme, indicating regulatory oversight.
-
MarketBeat Structural
MarketBeat serves as the publishing platform for analyst ratings concerning CARIS.
-
Irving Shared context
CARIS is located in the city of Irving.
-
Albemarle Corporation Transactional
CARIS engaged in block trades of Albemarle Corporation stock.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
4 events- CARIS gained FDA approval for its MI Cancer Seek test and was subsequently listed on the Nasdaq stock exchange.
- Blue Owl provided a $700 million platform-wide loan to Caris on August 8, 2026.
- Analyst ratings for Caris Life Sciences were published via MarketBeat, and the company is listed on the Nasdaq exchange.
- CARIS announced new leadership appointments, naming Luke Power as CFO and David Dean Halbert as CEO.